News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
165,566 Results
Type
Article (15007)
Company Profile (13)
Press Release (150546)
Multimedia
Podcasts (5)
Webinars (3)
Section
Business (41701)
Career Advice (208)
Deals (5643)
Drug Delivery (21)
Drug Development (21773)
Employer Resources (25)
FDA (3462)
Job Trends (3490)
News (71884)
Policy (5910)
Tag
2027 BioCapital Standard (1)
2027 Biotech Bay Elite (1)
Academia (1737)
Accelerated approval (11)
ADA (9)
Adcomms (12)
Allergies (33)
Alliances (13235)
ALS (72)
Alzheimer's disease (637)
Antibody-drug conjugate (ADC) (85)
Approvals (3649)
Artificial intelligence (180)
ASCO (102)
Autoimmune disease (65)
Automation (12)
Bankruptcy (37)
Best Places to Work (3024)
BIOSECURE Act (14)
Biosimilars (36)
Biotechnology (9)
Bladder cancer (67)
Brain cancer (31)
Breast cancer (264)
Cancer (2011)
Cardiovascular disease (136)
Career advice (198)
Career pathing (4)
CAR-T (114)
CDC (17)
Cell therapy (250)
Cervical cancer (20)
Clinical research (18474)
Collaboration (543)
Compensation (37)
Complete response letters (7)
COVID-19 (1164)
CRISPR (36)
C-suite (261)
Cystic fibrosis (34)
Data (2450)
Decentralized trials (1)
Denatured (1)
Depression (35)
Dermatology (22)
Diabetes (125)
Diagnostics (1945)
Digital health (11)
Diversity (3)
Diversity, equity & inclusion (9)
Drug discovery (88)
Drug pricing (29)
Drug shortages (2)
Duchenne muscular dystrophy (59)
Earnings (11185)
Editorial (14)
Employer branding (3)
Employer resources (21)
Events (22082)
Executive appointments (231)
FDA (4403)
Friedreich's ataxia (8)
Frontotemporal dementia (17)
Funding (676)
Gene editing (68)
Generative AI (6)
Gene therapy (224)
GLP-1 (169)
Government (1280)
Grass and pollen (1)
Guidances (84)
Healthcare (5077)
Hematology (62)
HIV (33)
Huntington's disease (7)
IgA nephropathy (33)
Immunology and inflammation (40)
Immuno-oncology (29)
Indications (51)
Infectious disease (1262)
Inflammatory bowel disease (63)
Inflation Reduction Act (2)
Influenza (23)
Intellectual property (56)
Interviews (19)
IPO (2888)
IRA (13)
Job creations (561)
Job search strategy (187)
JPM (4)
Kidney cancer (11)
Labor market (26)
Layoffs (66)
Leadership (2)
Legal (962)
Liver cancer (32)
Longevity (10)
Lung cancer (242)
Lymphoma (170)
Machine learning (16)
Management (6)
Manufacturing (184)
MASH (50)
Medical device (2607)
Medtech (2627)
Mergers & acquisitions (3071)
Metabolic disorders (245)
mRNA (46)
Multiple sclerosis (68)
NASH (7)
Neurodegenerative disease (122)
Neuropsychiatric disorders (13)
Neuroscience (1080)
NextGen: Class of 2026 (1692)
Non-profit (1914)
Now hiring (8)
Obesity (67)
Opinion (68)
Ovarian cancer (78)
Pain (62)
Pancreatic cancer (114)
Parkinson's disease (104)
Partnered (10)
Patents (107)
Patient recruitment (184)
Peanut (12)
People (16065)
Pharmaceutical (4)
Pharmacy benefit managers (2)
Phase 1 (6105)
Phase 2 (8294)
Phase 3 (5798)
Pipeline (2291)
Policy (85)
Postmarket research (652)
Preclinical (2679)
Press Release (18)
Prostate cancer (116)
Psychedelics (15)
Radiopharmaceuticals (68)
Rare diseases (247)
Real estate (1249)
Recruiting (12)
Regulatory (4938)
Reports (10)
Research institute (1973)
Resumes & cover letters (16)
Rett syndrome (3)
RNA editing (7)
RSV (15)
Schizophrenia (45)
Series A (91)
Series B (48)
Sickle cell disease (34)
Special edition (1)
Spinal muscular atrophy (30)
Sponsored (5)
Startups (1100)
Stomach cancer (3)
Supply chain (26)
Tariffs (11)
The Weekly (4)
Vaccines (344)
Venture capital (33)
Weight loss (32)
Women's health (27)
Worklife (3)
Date
Today (21)
Last 7 days (111)
Last 30 days (615)
Last 365 days (6562)
2026 (3275)
2025 (6695)
2024 (8148)
2023 (9670)
2022 (12613)
2021 (13940)
2020 (13185)
2019 (11596)
2018 (8698)
2017 (7980)
2016 (7930)
2015 (9393)
2014 (6922)
2013 (5666)
2012 (5764)
2011 (6024)
2010 (5176)
Location
Africa (198)
Alabama (63)
Alaska (3)
Arizona (89)
Arkansas (4)
Asia (10342)
Australia (2253)
California (2757)
Canada (721)
China (275)
Colorado (140)
Connecticut (122)
Delaware (134)
Europe (21937)
Florida (549)
Georgia (97)
Idaho (12)
Illinois (253)
India (22)
Indiana (117)
Iowa (8)
Japan (148)
Kansas (28)
Kentucky (19)
Louisiana (11)
Maine (12)
Maryland (393)
Massachusetts (2002)
Michigan (46)
Minnesota (138)
Mississippi (1)
Missouri (51)
Montana (7)
Nebraska (4)
Nevada (17)
New Hampshire (16)
New Jersey (1084)
New Mexico (6)
New York (1038)
North Carolina (329)
North Dakota (3)
Northern California (1378)
Ohio (95)
Oklahoma (8)
Oregon (9)
Pennsylvania (536)
Puerto Rico (5)
Rhode Island (18)
South America (269)
South Carolina (17)
Southern California (1064)
Tennessee (67)
Texas (589)
United States (10985)
Utah (75)
Vermont (1)
Virginia (73)
Washington D.C. (38)
Washington State (271)
West Virginia (2)
Wisconsin (32)
165,566 Results for "statens serum institut ssi".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Statens Serum Institut Large Danish Study Finds No Link Between Vaccines and Autism or 49 Other Health Conditions
July 16, 2025
·
2 min read
Press Releases
Bavarian Nordic and Serum Institute of India Expand Strategic Partnership with Chikungunya Vaccine Manufacturing Agreement
March 11, 2026
·
4 min read
Press Releases
Valneva and Serum Institute of India Announce Discontinuation of Chikungunya Vaccine License Agreement
January 1, 2026
·
7 min read
Press Releases
Sunflower Therapeutics Completes Major Installation of Daisy Petal™ Systems at the Serum Institute of India, the World’s Largest Vaccine Manufacturer
December 4, 2025
·
2 min read
Press Releases
SSI Diagnostica Group strengthens life science portfolio for vaccine development and quality control with acquisition of US-based multiplexing company
February 4, 2026
·
1 min read
Press Releases
InVitria Presents New Data at ASGCT 2026 on Recombinant Human Serum Albumin for Higher Lentiviral Vector Titers and Improved Cell Therapy Manufacturing
May 11, 2026
·
1 min read
Opinion
Biopharma Must Cope With The Fetal Bovine Serum Squeeze
The limited supply of this common reagent is set to drive drug prices higher, but there are ways for companies to lessen the impact.
February 17, 2026
·
5 min read
·
Tom Kutrubes
Press Releases
InVitria Showcases Exbumin® and Optibumin® 25 at IPEC Excipient World: Biologics Summit: Recombinant Human Serum Albumins Already Used in On-Market Approved Biologics
April 27, 2026
·
1 min read
Business
ImmunityBio, Serum Institute of India Agree on an Exclusive Arrangement for Global Supply of Bacillus Calmette-Guerin (BCG) Across All Cancer Types
ImmunityBio, Inc., has signed an exclusive global arrangement with the Serum Institute of India, the world’s largest manufacturer of vaccines by number of doses produced, to supply ImmunityBio with Bacillus Calmette-Guerin.
May 2, 2024
·
12 min read
Press Releases
Tryfacta, Inc. Awarded National Institutes of Health (NIH) Healthcare Staffing Contract
June 17, 2026
·
2 min read
1 of 16,557
Next
